On April 18, 2018, the Director of the USPTO Andrei Iancu informed the U.S. Senate Judiciary Committee that he aims to propose changes to America Invents Act reviews by this summer 2018. The Director told the Committee that...more
5/1/2018
/ America Invents Act ,
Claim Limitations ,
MPEP ,
New Guidance ,
Patent Applications ,
Patent Examinations ,
Patent Reform ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
USPTO
In a case of first impression, the PTAB recently decided that the doctrine of tribal sovereign immunity does not apply to inter partes review proceedings. See Mylan Pharmaceuticals Inc. v. Saint Regis Mohawk Tribe,...more
2/28/2018
/ Allergan Inc ,
FDA Approval ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Motion to Terminate ,
Mylan Pharmaceuticals ,
Native American Issues ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Sovereign Immunity ,
Tribal Governments